SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
34 hedge funds and large institutions have $77.1M invested in Sinovac Biotech, Ltd in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
34
Holding in Top 10
–
Calls
$128K
Puts
$3K
Top Buyers
| 1 | +$1.81M | |
| 2 | +$1.18M | |
| 3 | +$333K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$261K |
| 5 |
OTC
Opera Trading Capital
Paris,
France
|
+$230K |
Top Sellers
| 1 | -$6.24M | |
| 2 | -$206K | |
| 3 | -$151K | |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$141K |
| 5 |
Morgan Stanley
New York
|
-$128K |